Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy

Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy

Abstract Using new castration‐resistant prostate cancer (CRPC) cell lines developed from LNCaP cells as a model for CRPC, we searched for novel biomarkers by analyzing the proteins secreted in culture supernatants. The results showed that the levels of secretory leukocyte protease inhibitor (SLPI) i...

Full description

Bibliographic Details
Main Authors: Yu Miyazaki, Takayuki Goto, Xin Li, Kenji Nakayama, Kosuke Okasho, Masashi Takeda, Kei Mizuno, Hiroko Kimura, Masayuki Uegaki, Takayuki Sumiyoshi, Yuki Teramoto, Shusuke Akamatsu, Takashi Kobayashi, Osamu Ogawa, Takahiro Inoue
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
castration‐resistant
prostate cancer
proteomic analysis
secretory leukocyte protease inhibitor
tumor marker
Online Access:https://doi.org/10.1002/cam4.5134

Internet

https://doi.org/10.1002/cam4.5134

Similar Items